Skip to main content
Contact Us
Subscribe
E-Edition
86°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share
(NQ:
EDAP
)
1.870
-0.090 (-4.59%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share
< Previous
1
2
3
4
5
Next >
EDAP Reports First Quarter 2024 Financial Results
May 16, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
May 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
May 02, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
April 23, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Earnings Outlook For Edap TMS
March 26, 2024
Via
Benzinga
EDAP Stock Earnings: Edap TMS Misses EPS, Beats Revenue for Q4 2023
March 27, 2024
EDAP stock results show that Edap TMS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
March 27, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Earnings Scheduled For March 27, 2024
March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million.
Via
Benzinga
Recap: Edap TMS Q3 Earnings
November 09, 2023
Via
Benzinga
Edap TMS's Earnings Outlook
August 23, 2023
Via
Benzinga
Recap: Edap TMS Q1 Earnings
May 17, 2023
Via
Benzinga
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
March 13, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
March 04, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
February 29, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
February 01, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
January 08, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
January 02, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
December 12, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
December 06, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
November 30, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
November 20, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Third Quarter 2023 Financial Results
November 09, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at the Jefferies London Healthcare Conference
November 06, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
October 26, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference
September 06, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Second Quarter 2023 Financial Results
August 24, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP TMS SA to Announce Second Quarter 2023 Financial Results on August 24, 2023
August 10, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
July 26, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at the Jefferies Healthcare Conference
May 24, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.